SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
1.540
+0.130 (9.22%)
May 14, 2025, 12:59 PM - Market open

SLS Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
1407334498855
Upgrade
Market Cap Growth
72.64%115.38%-30.05%-44.69%59.80%162.41%
Upgrade
Enterprise Value
1135331286248
Upgrade
Last Close Price
1.411.041.062.365.535.81
Upgrade
PS Ratio
---48.5911.5628.93
Upgrade
PB Ratio
4.627.73-4.2610.024.321.97
Upgrade
P/TBV Ratio
5.439.69-16.544.772.70
Upgrade
EV/Sales Ratio
---28.288.2125.15
Upgrade
Debt / Equity Ratio
0.030.11-0.110.200.040.04
Upgrade
Asset Turnover
---0.040.210.06
Upgrade
Quick Ratio
4.121.460.181.104.292.86
Upgrade
Current Ratio
4.641.720.231.144.632.99
Upgrade
Return on Equity (ROE)
-144.90%-4147.88%--327.81%-85.70%-98.41%
Upgrade
Return on Assets (ROA)
-58.79%-153.57%-174.27%-84.58%-33.87%-33.88%
Upgrade
Return on Capital (ROIC)
-89.26%-1159.93%--148.19%-48.88%-60.20%
Upgrade
Earnings Yield
-19.33%-42.19%-109.87%-85.00%-23.56%-30.48%
Upgrade
FCF Yield
-24.02%-48.37%-92.42%-49.00%-29.62%-18.95%
Upgrade
Buyback Yield / Dilution
-117.38%-120.33%-43.21%-25.29%-94.07%-211.76%
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q